Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (40)

2024

  1. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  2. The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 507-515

  3. The imperative for quality control programs in Monkeypox virus DNA testing by PCR: CIBERINFEC quality control

    Journal of Medical Virology, Vol. 95, Núm. 11

  4. Update on Bimervax® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)

    Revista Espanola de Quimioterapia

2022

  1. Does infection predispose to thrombosis during long-term ventricular assist device support?

    Artificial Organs, Vol. 46, Núm. 7, pp. 1399-1408

2021

  1. Antibody response in patients admitted to the hospital with suspected SARS-CoV-2 infection: results from a multicenter study across Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 6, pp. 1343-1349

  2. Hepatitis C reflex testing in Spain in 2019: A story of success

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 3, pp. 119-126

  3. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  4. Overview of virus and cancer relationships. Position paper

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 6, pp. 525-555

  5. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

  6. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. COVID-19 comes 40 years after aids – Any lesson?

    AIDS Reviews, Vol. 22, Núm. 1, pp. 1-15

  2. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  3. Covid-19 comes 40 years after aids – any lesson?

    AIDS Reviews, Vol. 22, Núm. 2, pp. 63-77

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  3. Diagnosis of hepatitis C virus infection in Spain: An opportunity to improve

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 4, pp. 231-238

2018

  1. Candidemia and colonization by Candida auris, a diagnostic challenge

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 4, pp. 253-255

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088